Company Overview and News

25
Oil slumps 3 percent on OPEC supply, China's tariffs

2018-06-15 reuters
NEW YORK (Reuters) - Oil prices fell more than $2 a barrel Friday after two of the world’s biggest producers indicated they might increase output at next week’s OPEC meeting, while U.S. exports were threatened by potential Chinese tariffs on crude oil and refined products.
BHI

25
Oil Explorers Expand Drilling in U.S. Fields - Bloomberg

2018-06-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BHI

39
Baker Hughes: US Drillers Add Oil Rigs for Fourth Week in a Row

2018-06-15 rigzone
June 15 (Reuters) - U.S. energy companies added one oil rig this week, the fourth consecutive week of increases, despite a 9 percent decline in crude prices over the past four weeks.
BHI GEC GE GNE

25
US Oil Rig Count Ticks Up Again as Crude Price Slides

2018-06-15 247wallst
The number of land rigs drilling for oil in the United States in the week ending June 15 totaled 863, up by one compared with the previous week and up by 116 compared with a total of 747 a year ago. Including 194 other land rigs drilling for natural gas and two listed as miscellaneous, there are a total of 1,059 working rigs in the country, down by three week over week and up by 126 year over year.
BHI

25
Rig Count Falters Amid Oil Price Correction

2018-06-15 oilprice
Julianne Geiger is a veteran editor, writer and researcher for US-based Divergente LLC consulting firm, and a member of the Creative Professionals Networking Group.
BHI

39
U.S. drillers add oil rigs for fourth week in a row -Baker Hughes

2018-06-15 reuters
June 15 (Reuters) - U.S. energy companies added one oil rig this week, the fourth consecutive week of increases, despite a 9 percent decline in crude prices over the past four weeks.
BHI GEC GE GNE

34
Baker Hughes Wins Cheniere's Corpus Christi Expansion Deal

2018-06-15 zacks
Baker Hughes, a GE company (BHGE - Free Report) recently received a contract from Cheniere Energy, Inc. (LNG - Free Report) to provide turbomachinery equipment for the latter’s Corpus Christi LNG facility expansion. Notably, last month Cheniere announced its intention of moving forward with its South Texas gas terminal’s expansion plans.
BHI CQP DK SPG.PRJ LNG HFC BHGE SPG LNG

25
OIL Weekly: Wait And See Approach Will Prevail Until Upcoming OPEC Meeting

2018-06-13 seekingalpha
Net speculative positioning on crude oil pursued its steady plunge, reaching the seventh consecutive week decline.
BHI 9696

25
Identifying Risk In MLPs: I Wish I Bought Enterprise Products Partners

2018-06-13 seekingalpha
Enterprise Products Partners (EPD) is a master limited partnership (‘MLP’) with a focus on natural gas and natural gas liquids. They have earned a reputation for being a blue chip MLP due to their history of consistent and generous distribution increases in addition to a strong balance sheet. Shares trade at a 5.8% yield in spite of a recent run up in price. Still, future growth is almost certain to be nothing like the past - what does this mean for their distribution? I analyze the key metric for EPD and give my verdict on shares.
BHI EPD MMP

25
Crunch Time For OPEC

2018-06-13 think.ing
OPEC members descend on Vienna next week for the official semi-annual meeting on June 22. Will members of the OPEC+ deal decide to ease production cuts? While some members appear to be against the idea, we believe that we will see a gradual lifting of cuts
BHI BHGE

115
Oil & Gas Stock Roundup: Devon's Asset Sale, Exxon's Brazil Win & More

2018-06-12 zacks
On the news front, Devon Energy Corp. (DVN - Free Report) agreed to sell interests in certain midstream assets apart from boosting its share buyback program, while Exxon Mobil Corp. (XOM - Free Report) snapped up offshore stakes in Brazil’s fourth pre-salt bid round.
BHI XOM ENGI ENLK WTR SDRL DVN UTX VLO ENLC

85
Just The Numbers Plus For 4 Pipeline Performance Additive Companies

2018-06-12 seekingalpha
With Permian pipeline capacity beyond full, every possible measure is being taken to move oil from the Permian before slowing drilling and production.
DRA BRK.A BHI GEC GE KMG WTI GNE IOSP

25
Dollar Seeks Central Bank Guidance

2018-06-12 seekingalpha
The Trump-Kim summit came and went with little market movement. Instead, investors and dealers remain focused on a plethora of macro-events and data coming over the next few days. The meeting has produced much positive symbolism, but little in the way of substance as vague pledges just doesn't cut it for markets.
BHI

39
Either GE Or Its Dividend, And Possibly Both, Are Set To Shrink

2018-06-12 seekingalpha
On Friday, 8 June 2018, General Electric (NYSE:GE) took a pass on cutting its dividend, as the company declared that it would sustain its current quarterly cash payouts to the company's shareholders at its current level of 12 cents per share.
BHI GE GEC BHGE GNE

58
Consolidation of the oil and gas sector not fast enough

2018-06-12 thestar.com.my
The steady recovery in crude oil prices over the past one year has yet to have a big positive impact on OGSE players. This is partly because oil majors have yet to increase their capex in a big way.
RDS.B RDS.A XOM RDSB RDSA 8133 5255 9466 BHI 7206 5703 RYDBF RYDAF BSMAF 1818

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

11h - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to BHI / Baker Hughes Inc. on message board site Silicon Investor.

Baker Hughes Webhire (HIRE) - Enters the Softbank Web
BHIT (online auction site) BHI
CUSIP: 057224107